Cannabidiol‐induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET

Disulfiram (DSF), an established alcohol‐aversion drug, is a candidate for repurposing in cancer treatment. DSF’s antitumor activity is supported by preclinical studies, case reports, and small clinical trials; however, ongoing clinical trials of advanced‐stage cancer patients encounter variable res...

Descripción completa

Detalles Bibliográficos
Autores principales: Buchtova, Tereza, Skrott, Zdenek, Chroma, Katarina, Rehulka, Jiri, Dzubak, Petr, Hajduch, Marian, Lukac, David, Arampatzis, Stefanos, Bartek, Jiri, Mistrik, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978514/
https://www.ncbi.nlm.nih.gov/pubmed/34632694
http://dx.doi.org/10.1002/1878-0261.13114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978514/
https://www.ncbi.nlm.nih.gov/pubmed/34632694
http://dx.doi.org/10.1002/1878-0261.13114

Ejemplares similares